Highest EBITDA
legend_toggleExplore a diverse array of industries, each represented by companies that have excelled in generating substantial EBITDA.
| name | PRICE | $ CHANGE | % CHANGE | MARKET CAP | VOLUME | AVG. VOLUME | arrow_downwardEBITDA | TECHNICALS | DIVIDEND Y | ROI 1Y | Score language | LAST 7 DAYS | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
STEMStem | $0.40 | -$0.04 | arrow_drop_down9.39% | $67.60M | 4.21M | 4.66M | -$162.46M | Neutralremove | - | -90.98% | AI Analysis | |||||
GTLBGitLab | $52.35 | $1.18 | arrow_drop_up2.30% | $8.46B | 1.85M | 1.82M | -$162.81M | Neutralremove | - | 8.85% | AI Analysis | |||||
BEAMBeam Therapeutics | $26.04 | $0.53 | arrow_drop_up2.07% | $2.10B | 633.80K | 664.44K | -$162.88M | Neutralremove | - | 7.11% | AI Analysis | |||||
FATEFate Therapeutics | $4.00 | $0.12 | arrow_drop_up3.09% | $455.51M | 1.00M | 915.94K | -$163.43M | Neutralremove | - | 56.86% | AI Analysis | |||||
ADPTAdaptive Biotechnologies | $4.78 | $0.17 | arrow_drop_up3.68% | $679.84M | 746.75K | 842.54K | -$164.09M | Neutralremove | - | -13.40% | AI Analysis | |||||
OPKOPKO Health | $1.59 | -$0.03 | arrow_drop_down1.85% | $1.12B | 3.48M | 3.33M | -$165.45M | Neutralremove | - | -1.85% | AI Analysis | |||||
FGENFibroGen | $0.41 | -$0.00 | arrow_drop_down0.95% | $44.98M | 600.89K | 834.75K | -$165.83M | Neutralremove | - | -47.34% | AI Analysis | |||||
NVCRNovocure Ltd | $17.84 | $0.23 | arrow_drop_up1.30% | $1.90B | 567.20K | 771.56K | -$166.41M | Neutralremove | - | -5.20% | AI Analysis | |||||
MAXNMaxeon Solar Technologies Ltd | $0.10 | $0.01 | arrow_drop_up15.38% | $121.87M | 103.82M | 55.43M | -$168.66M | Neutralremove | - | -99.20% | AI Analysis | |||||
BENF BENFBeneficient | $1.26 | $0.03 | arrow_drop_up2.43% | $5.40M | 155.19K | 12.05M | -$169.20M | Neutralremove | - | -99.45% | AI Analysis | |||||
LMNDLemonade | $18.42 | $0.20 | arrow_drop_up1.09% | $1.29B | 1.17M | 870.00K | -$170.80M | Neutralremove | - | 46.65% | AI Analysis | |||||
NRIXNurix Therapeutics | $25.06 | $0.32 | arrow_drop_up1.29% | $1.59B | 684.31K | 506.24K | -$172.24M | Neutralremove | - | 181.25% | AI Analysis | |||||
MTTRMatterport | $4.54 | $0.00 | 0.00% | $1.46B | 2.48M | 1.74M | -$172.38M | Neutralremove | - | 99.12% | AI Analysis | |||||
TSVT2seventy bio | $4.87 | $0.15 | arrow_drop_up3.17% | $249.76M | 171.46K | 229.32K | -$176.56M | Neutralremove | - | 30.91% | AI Analysis | |||||
KYMRKymera Therapeutics | $49.03 | $2.59 | arrow_drop_up5.57% | $3.05B | 478.05K | 336.99K | -$176.96M | Neutralremove | - | 156.83% | AI Analysis | |||||
VRMVroom | $7.31 | -$0.01 | arrow_drop_down0.13% | $13.32M | 122.31K | 41.30K | -$177.43M | Neutralremove | - | -92.44% | AI Analysis | |||||
ARQTArcutis Biotherapeutics | $10.14 | -$0.26 | arrow_drop_down2.50% | $1.21B | 4.39M | 1.94M | -$178.29M | Neutralremove | - | 57.69% | AI Analysis | |||||
ALXOALX Oncology Holdings | $2.17 | $0.03 | arrow_drop_up1.40% | $114.82M | 401.60K | 444.65K | -$179.51M | Neutralremove | - | -57.94% | AI Analysis | |||||
EXAIExscientia plc | $5.20 | -$0.02 | arrow_drop_down0.38% | $638.90M | 927.81K | 584.83K | -$180.21M | Neutralremove | - | -0.00% | AI Analysis | |||||
 BYNDBeyond Meat | $6.33 | $0.04 | arrow_drop_up0.63% | $409.74M | 1.55M | 1.62M | -$180.57M | Neutralremove | - | -37.81% | AI Analysis |
Showing 4821-4840 of 4977
Results per page:
About Highest EBITDA
Discover the stocks with the highest EBITDA, a significant financial metric indicating a company's operational profitability. EBITDA, or earnings before interest, taxes, depreciation, and amortization, reflects a firm's ability to generate profits from its core operations without factoring in financing and accounting decisions.
Investors seek companies with robust EBITDA figures as it showcases their potential for sustainable growth and cash flow generation. High EBITDA stocks often demonstrate strong financial health and efficiency, making them attractive choices for long-term investment strategies.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools